Transaction · 0001104659-26-108247

Capponi Vincent

Capponi Vincent, PRES, reported an open-market or private purchase at Cytosorbents Corp involving 1800.000000 shares for an estimated $10926.00. Reported holdings after the transaction were 40114.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PPRES
CTSOCytosorbents Corp
Trade date
Sep 14, 2026
Filing date
Sep 16, 2026
View on SEC Insider profile
Disclosed value$10.9kShares × reported price
Shares traded1.80k$6.07 per share
Holdings after40.1kDirect
% of reported position traded4.7%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 38,314 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

CTSO price since this filing

Daily closing prices, with the filing date and available return windows
CTSO · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago +11.9%
Returns since7d -14.3%30d -46.6%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001104659-26-108247
Common Stock
Transaction date
Sep 14, 2026
Filed Sep 16, 2026, 08:05 PM · 2d delay
Shares
1,800 sh
$6.07 per share
Estimated value
$10.9k
Computed from shares × price
Holdings after
40,114 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

+22 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and COO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This transaction reported on this Form 4 reflects an open market purchase made by the Reporting Person.

  2. F2

    Includes: (i) the following RSUs that will be settled into Common Stock upon vesting upon a "Change In Control" of CytoSorbents Corporation (the "Issuer") as defined in the Amended and Restated CytoSo…

  3. F3

    (continued from footnote 2) (ii) the following RSUs, which vest in equal parts on the first year anniversary of the date of grant and the second year anniversary of the date of grant, subject to the R…

  4. F4

    (continued from footnote 3) (iii) 25,736 shares of Common Stock owned by the Reporting Person.

  5. F5

    Reflects the 1-for-20 reverse stock split effected by the Issuer on September 8, 2026.

Original filing · 0001104659-26-108247
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CTSO